/**/ RNS Number : 2696M Imaging Biometrics Limited 14 July 2026 Imaging Biometrics Limited (“IBAI” or the “Company”) Sub-division Further to the announcements of 12 May and 3 June, the Company is pleased to confirm that the sub-division has completed with a resulting 246,709,789 ordinary shares of £0.005. The Company has received
/**/ RNS Number : 4746H Imaging Biometrics Limited 09 June 2026 Imaging Biometrics Limited (“Company”) 9 June 2026 Publication of Phase 1 Clinical Trial of Oral Gallium Maltolate (GaM) in Recurrent Glioblastoma and Reopening of Expanded Access Programme Imaging Biometrics Limited (LSE: IBAI) announces the publication in the peer-reviewed journal Neuro-Oncology Advances describing
/**/ RNS Number : 0999H Imaging Biometrics Limited 05 June 2026 IMAGING BIOMETRICS LIMITED (“IBAI” or the “Company”) (LSE: IBAI) 5 June 2026 IB Neuro™ Commercialisation Plan – ASCO 2026 Phase II Results and Strategic Revenue Pathway Imaging Biometrics Limited (LSE: IBAI) is pleased to update shareholders on the EAF151 Phase
/**/ RNS Number : 8611G Imaging Biometrics Limited 03 June 2026 03 June 2026 Imaging Biometrics Limited (“IBAI” or the “Company”) Result of AGM Imaging Biometrics Limited announces that at the annual general meeting of the Company held earlier today, all resolutions were duly passed. For information, the proxy votes
/**/ RNS Number : 5405G Imaging Biometrics Limited 03 June 2026 IMAGING BIOMETRICS LIMITED (“IBAI” or the “Company”) (LSE: IBAI) AGM Statement and Business Update 3 June 2026 Imaging Biometrics Limited (LSE: IBAI) is pleased to provide this update to shareholders ahead of its Annual General Meeting being held today. The Group develops quantitative
/**/ RNS Number : 0578E Imaging Biometrics Limited 13 May 2026 Imaging Biometrics Limited (“IBAI” or the “Company”) AMENDMENT TO NOTICE OF ANNUAL GENERAL MEETING The Company notes an error to RNS 12 May 2026 (RNS Number: 0280E), that incorrectly stated that the ordinary shares of £0.01 will be sub-divided into one
/**/ RNS Number : 0280E Imaging Biometrics Limited 12 May 2026 Imaging Biometrics Limited (“IBAI” or the “Company”) NOTICE OF ANNUAL GENERAL MEETING Imaging Biometrics Limited, the Main Market listed healthcare technology group, is pleased to announce that its Annual General Meeting (“AGM”) will be held at IFC5, St Helier, Jersey, JE1
/**/ RNS Number : 4862D Imaging Biometrics Limited 08 May 2026 Imaging Biometrics Limited (“IBAI” or the “Company”) KIRKSTALL AWARDED BBSRC/NC3Rs GRANT FOR GLIOBLASTOMA ‘TUMOUR ON A CHIP’ RESEARCH Imaging Biometrics Limited, the Main Market listed healthcare technology group, is pleased to announce that its subsidiary Kirkstall Limited (“Kirkstall”) has been
/**/ RNS Number : 6589C Imaging Biometrics Limited 30 April 2026 Imaging Biometrics Limited (“IBAI” or the “Company”) Publication of Annual Report for the Year Ended 31 December 2025 The Board of IBAI Ltd is pleased to announce the Company’s audited financial statements for the year ended 31 December 2025. The
/**/ RNS Number : 6987T Imaging Biometrics Limited 19 February 2026 Imaging Biometrics Limited (“IBAI” or the “Company”) Board Appointment Imaging Biometrics Limited (LSE: IBAI) is pleased to announce the appointment of John Charles Richardson as a Non-Executive Director with effect from 1 March 2026 and will become a member of the
